About cancer screenings and saving lives: measuring the effects of cancer screening programs through meta-analyses-A comment to the meta-analysis "Estimated Lifetime Gained With Cancer Screening Tests" by Bretthauer et al. (2023).
作者信息
Stracci Fabrizio, Martinelli Domenico, Anedda Francesca Maria, Caminiti Marta, Mantovani William, Pettinicchio Valentina, Sinopoli Alessandra, Vitale Francesco, Siliquini Roberta, Mazzucco Walter
机构信息
Section of Public Health, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Hygiene Unit, Department of Medical and Surgical Sciences, Policlinico Foggia Hospital, University of Foggia, Foggia, Italy.
出版信息
Front Public Health. 2024 Apr 9;12:1376377. doi: 10.3389/fpubh.2024.1376377. eCollection 2024.
Abstract
摘要
相似文献
1
About cancer screenings and saving lives: measuring the effects of cancer screening programs through meta-analyses-A comment to the meta-analysis "Estimated Lifetime Gained With Cancer Screening Tests" by Bretthauer et al. (2023).关于癌症筛查与挽救生命：通过荟萃分析评估癌症筛查项目的效果——对Bretthauer等人（2023年）的荟萃分析《癌症筛查测试估计获得的终身收益》的评论
Front Public Health. 2024 Apr 9;12:1376377. doi: 10.3389/fpubh.2024.1376377. eCollection 2024.
2
CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life.结肠镜筛查可使生命延长 110 天；其他癌症筛查测试不能延长生命。
Ann Intern Med. 2024 Jan;177(1):JC9. doi: 10.7326/J23-0112. Epub 2024 Jan 2.
3
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述：观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.
4
Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials.无症状成年人的疾病筛查能否拯救生命？荟萃分析和随机试验的系统评价。
Int J Epidemiol. 2015 Feb;44(1):264-77. doi: 10.1093/ije/dyu140. Epub 2015 Jan 15.
5
Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes?乳腺癌、宫颈癌和结直肠癌筛查推广的障碍：法国国家计划仍需实现哪些目标？
BMC Health Serv Res. 2014 Oct 4;14:465. doi: 10.1186/1472-6963-14-465.
6
Cost-Effectiveness of Cancer Screening: Health and Costs in Life Years Gained.癌症筛查的成本效益：以获得的健康生命年和成本来衡量。
Am J Prev Med. 2019 Dec;57(6):792-799. doi: 10.1016/j.amepre.2019.07.027.
7
[Screening and early diagnosis of cancers: 2 ways for a same goal].[癌症的筛查与早期诊断：通向同一目标的两种方式]
Rev Prat. 2010 Feb 20;60(2):183-8, 190.
8
Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.癌症筛查检查不依从与无关原因死亡率的关联：PLCO 癌症筛查试验的二次分析。
JAMA Intern Med. 2019 Feb 1;179(2):196-203. doi: 10.1001/jamainternmed.2018.5982.
9
Cancer screenings decline significantly during pandemic.在疫情期间，癌症筛查显著减少。
Cancer. 2020 Sep 1;126(17):3894-3895. doi: 10.1002/cncr.33128.
10
The aggregate value of cancer screenings in the United States: full potential value and value considering adherence.美国癌症筛查的总价值：充分潜力价值和考虑依从性的价值。
BMC Health Serv Res. 2023 Aug 7;23(1):829. doi: 10.1186/s12913-023-09738-4.
引用本文的文献
1
Evaluation of the Slovenian Breast Cancer Screening Programme: Years of Life Gained and Avoided Deaths.斯洛文尼亚乳腺癌筛查项目评估：获得的生命年数与避免的死亡人数
Cancers (Basel). 2025 Feb 22;17(5):742. doi: 10.3390/cancers17050742.
2
Deceptive Measures of "Success" in Early Cancer Detection.早期癌症检测中“成功”的欺骗手段。
Curr Oncol. 2024 Aug 30;31(9):5140-5150. doi: 10.3390/curroncol31090380.
本文引用的文献
1
Testing Whether Cancer Screening Saves Lives: Implications for Randomized Clinical Trials of Multicancer Screening.检验癌症筛查是否能挽救生命：对多癌种筛查随机临床试验的启示
JAMA Intern Med. 2023 Nov 1;183(11):1255-1258. doi: 10.1001/jamainternmed.2023.3781.
2
Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials.癌症筛查试验带来的预期寿命获益：一项随机临床试验的荟萃分析。
JAMA Intern Med. 2023 Nov 1;183(11):1196-1203. doi: 10.1001/jamainternmed.2023.3798.
3
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.基于前列腺特异性抗原的筛查对前列腺癌发病率和死亡率影响的详细评估：前列腺癌筛查的欧洲随机研究 Rotterdam 部分 21 年随访结果。
Eur Urol. 2023 Oct;84(4):426-434. doi: 10.1016/j.eururo.2023.03.016. Epub 2023 Apr 5.
4
Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.自我采样用于人乳头瘤病毒检测是否有可能增加宫颈癌筛查？观察性研究和随机临床试验的更新荟萃分析。
Front Public Health. 2022 Dec 8;10:1003461. doi: 10.3389/fpubh.2022.1003461. eCollection 2022.
5
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.结肠镜筛查对结直肠癌发病风险和相关死亡的影响。
N Engl J Med. 2022 Oct 27;387(17):1547-1556. doi: 10.1056/NEJMoa2208375. Epub 2022 Oct 9.
6
The IARC Perspective on Cervical Cancer Screening.国际癌症研究机构对宫颈癌筛查的观点。
N Engl J Med. 2022 Feb 10;386(6):607. doi: 10.1056/NEJMc2119177.
7
All-cause mortality in multi-cancer screening trials.多癌种筛查试验中的全因死亡率。
J Med Screen. 2022 Mar;29(1):1-2. doi: 10.1177/09691413211060680. Epub 2021 Dec 1.
8
Contemporary issues in the implementation of lung cancer screening.肺癌筛查实施中的当代问题。
Eur Respir Rev. 2021 Jul 20;30(161). doi: 10.1183/16000617.0288-2020. Print 2021 Sep 30.
9
The Evaluation of Cancer Screening: Concepts and Outcome Measures.癌症筛查评估：概念和结果测量。
Med Clin North Am. 2020 Nov;104(6):939-953. doi: 10.1016/j.mcna.2020.07.002. Epub 2020 Sep 17.
10
Lung Cancer Screening Uptake in the United States.美国肺癌筛查的接受情况。
Chest. 2020 Jan;157(1):236-238. doi: 10.1016/j.chest.2019.08.2176.
Zotero 插件